898 resultados para Neuromuscular blocking drugs
Resumo:
Pós-graduação em Ciências da Motricidade - IBRC
Resumo:
Pós-graduação em Ciências da Motricidade - IBRC
Resumo:
A Facilitação Neuromuscular Proprioceptiva – FNP – é uma técnica que cada vez mais vem sendo utilizada no treinamento muscular de pessoas saudáveis e atletas. Pesquisas vêm mostrando que exercícios de resistência, dentre eles a FNP, são capazes de converter o tipo das fibras musculares treinadas. Esta pesquisa teve como objetivo verificar a eficiência da FNP no acréscimo de força muscular e verificar por métodos não invasivos se haveria indicativo de conversão de tipo de fibra muscular após o treinamento. Um grupo amostral de 22 jovens, universitárias do sexo feminino com idade entre 18 e 25 anos e fisicamente ativas, foi dividido em: grupo controle (GC n=10) e grupo experimental (GE n=12). Foram inicialmente mensurados: I - força da Contração Voluntária Máxima - CVM do músculo quadríceps por dinamometria analógica e root mean square - RMS e II - área de ativação muscular por eletromiografia de superfície (EMG) de todos os sujeitos. Após a primeira coleta de dados o GE realizou treinamento baseado na FNP no membro inferior dominante por 15 sessões em 5 semanas. Ao final, nova mensuração foi feita em todos. Quanto à força muscular, houve acréscimo em ambos os grupos, significativa no GC (p<0,01) e no GE (p<0,05); para RMS e tempo de CVM, houve aumento não significativo no GE, mas a interação Vxt aumentou significativamente para este grupo. Os resultados corroboram a literatura ao mostrar que músculos com predomínio de fibras resistentes (fibras I/ II A) possuem maior tempo de contração com mais ativação elétrica e de que a FNP é capaz fibras tipo II B para II A. Concluiu-se que para a amostra estudada o treinamento foi eficiente no acréscimo de força muscular e os dados EMG apresentados mostram fortes evidências da conversão das fibras do músculo treinado.
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Resumo:
Introduction Visceral leishmaniasis (VL) is caused by the intracellular protozoan Leishmania donovani complex. VL may be asymptomatic or progressive and is characterized by fever, anemia, weight loss and the enlargement of the spleen and liver. The nutritional status of the patients with VL is a major determinant of the progression, severity and mortality of the disease, as it affects the clinical progression of the disease. Changes in lipoproteins and plasma proteins may have major impacts in the host during infection. Thus, our goal was evaluate the serum total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglycerides, glucose, albumin, globulin and total protein levels, as well as the body composition, of VL patients before and after treatment. Methods Nutritional evaluation was performed using the bioelectrical impedance analysis (BIA) to assess body composition. Biochemical data on the serum total cholesterol, HDL, LDL, triglycerides, glucose, albumin, globulin and total protein were collected from the medical charts of the patients. Results BIA indicated that both pre-treatment and post-treatment patients exhibited decreased phase angles compared to the controls, which is indicative of disease. Prior to treatment, the patients exhibited lower levels of total body water compared to the controls. Regarding the biochemical evaluation, patients with active VL exhibited lower levels of total cholesterol, HDL, LDL and albumin and higher triglyceride levels compared to patients after treatment and the controls. Treatment increased the levels of albumin and lipoproteins and decreased the triglyceride levels. Conclusions Our results suggest that patients with active VL present biochemical and nutritional changes that are reversed by treatment.
Resumo:
Millions of people and animals suffer from superficial infections caused by a group of highly specialized filamentous fungi, the dermatophytes, which only infect keratinized structures. With the appearance of AIDS, the incidence of dermatophytosis has increased. Current drug therapy used for these infections is often toxic, long-term, and expensive and has limited effectiveness; therefore, the discovery of new anti dermatophytic compounds is a necessity. Natural products have been the most productive source for new drug development. This paper provides a brief review of the current literature regarding the presence of dermatophytes in immunocompromised patients, drug resistance to conventional treatments and new anti dermatophytic treatments.
Resumo:
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
With the fast growth of cancer research, new analytical methods are needed to measure anticancer drugs. This is usually accomplished by using sophisticated analytical instruments. Biosensors are attractive candidates for measuring anticancer drugs, but currently few biosensors can achieve this goal. In particular, it is challenging to have a general method to monitor various types of anticancer drugs with different structures. In this work, a biosensor was developed to detect anticancer drugs by modifying carbon paste electrodes with glutathione-s-transferase (GST) enzymes. GST is widely studied in the metabolism of xenobiotics and is a major contributing factor in resistance to anticancer drugs. The measurement of anticancer drugs is based on competition between 1-chloro-2,4-dinitrobenzene (CDNB) and the drugs for the GST enzyme in the electrochemical potential at 0.1 V vs. Ag/AgCl by square wave voltammetry (SWV) or using a colorimetric method. The sensor shows a detection limit of 8.8 mu M cisplatin and exhibits relatively long life time in daily measurements. (C) 2014 Elsevier B.V. All rights reserved.
Resumo:
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Resumo:
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)